How new Insights into ESR1 Mutant Breast Cancers may lead to Novel Therapy Targets
 

In this interview, we speak to Steffi Oesterreich, PH.D., from the University of Pittsburgh, about how new insights into a gene mutation present in 20-30% of breast cancer recurrences may have a silver lining, leading to novel treatment opportunities.

More...